… Thus, our data provide a novel lncRNA GAS5 that could be a … In summary, our study
demonstrates that lncRNA GAS5 is down-… Our data provide a novel lncRNA GAS5 that could be a …

… GAS5 may have diverse … GAS5 knockdown reversed the elevation of fibrosis-related
protein (α-SMA, collagen I and fibronectin) in cardiac tissues of diabetic mice, suggesting GAS5 …

… However, the function of lncRNA GAS5 in diabetic cardiomyopathy is still not clear. Thus, in
… the progression of the lncRNA GAS5 in diabetic cardiomyopathy. lncRNAs can function as …

… Diabetic cardiomyopathy (DCM) is one of the primary complications of the cardiovascular
system due to diabetes‑… lncRNA GAS5 has been revealed to be aberrantly increased in …

… Gas5 on DCM is insufficient, the cardiac Gas5 could be a valuable target to improve DCM. …
of lncRNAs in the development of diabetic cardiomyopathy. We show a number of lncRNAs …

… The lncRNA known as growth arrest-specific 5 (GAS5) emerged as a … GAS5 was observed
to be elevated in both AC16 cardiomyocytes treated with HG and in a rat model of diabetic …

… differentially expression plays an important role in septic mice, and GAS5 could be a new …
in lncRNA GAS5 levels in the heart tissue of septic mice and the CLP + shGAS5 group. GAS5 …

… GAS5 with pressure overload-induced cardiac … that GAS5 attenuated cardiac fibrosis in
mice by regulating PTEN/MMP-2. Those two studies demonstrated that GAS5 decreased cardiac …

… found that lncRNA GAS5 was significantly repressed in the cardiac tissue of diabetic rats;
GAS5 … IL-1β and IL-18 levels in HG-treated cardiac muscle cells (HL-1 cells). They showed that …

… diabetic patients. In this study, we aimed to identify the functional role of long noncoding RNA
GAS5 … Diabetic cardiomyopathy (DCM), characterized by cardiac remodeling and diastolic …